GE Healthcare
EU REACH Substance Communication Guide June 2022
Guide
2 Pages
Preview
Page 1
GE Healthcare
Anesthesia and Respiratory Care EU REACH Substance Communication PN: 5932196
Please verify that you are using the latest released revision of this document. Information pertaining to this document is maintained in the MyWorkshop system.
Revision history table: Rev
Change content (WHAT)
Reason for change (WHY)
Author
1
Initial release
Show compliance to EU REACH Candidate List 10-Jun-2022
Charlie Andrew (212552051)
5932196 Template: DOC2287350 Rev 4
Page 1 of 2
GE Healthcare
Surya Kunduri REACH Regulations Leader Product Compliance Engineering [email protected] M +33 664083106 Charlie Andrew Standards and Regulatory Engineer ARC Engineering [email protected] M +1 3366159396
GE Healthcare works with its suppliers to ensure compliance of articles imported or manufactured within the European Union that are subject to the REACH regulation (EC- No 1907/2006), Article 33, and used in the production of GE Healthcare products. Regarding the application of Article 33 of the REACH regulation and the publication of the Candidate List of Substances of Very High Concern (SVHC) according to Article 59 of REACH regulation, GE Healthcare is aware of its legal obligations and will comply with them. GE Healthcare articles do not "intentionally release" substances under normal conditions of use. Based on information from our suppliers to date, these substances are present in the following products at a concentration that may be greater than the threshold of 0.1% (w/w) at the article level:
Product Name(s)
Substance name
CAS Numbers
Aestiva MRI
Boron oxide (B2O3) Lead oxide (PbO) Lead
1303-86-2 1317-36-8 7439-92-1
Boron oxide (B2O3) Silicic acid, lead salt Lead oxide (PbO) Lead
1303-86-2 11120-22-2 1317-36-8 7439-92-1
Lead
7439-92-1
Lead 1H-Imidazole, 2-methyl-
7439-92-1 693-98-1
Avance CS2 Aisys CS2 Carestation 650/650c/620 Carestation 750/750c 9100C NXT Tec 8 vaporizer Tec 6 Plus vaporizer Mural Connect CARESCAPE R860
5932196 Template: DOC2287350 Rev 4
Page 2 of 2